https://www.selleckchem.com/pr....oducts/Rapamycin.htm
At 2months, intervention group reported better mental well-being (0.9, 95%CI 0.1-1.8, p=0.025) and less depressive symptoms (-1.0; 95%CI -1.7 to-0.3, p=0.004). Within group at 2months, intervention group had improvement in mental well-being (SWEMWBS 22.5-23.4, p=0.011), cognitive function (MOCA 24.6-25.8, p0.001; VFT 38.7-42.1, p0.001), depressive symptoms (GDS 4.1-3.1, p0.001), and sleep quality (PSQI 8.3-6.7, p0.001). All these changes, except mental well-being, were sustained at 4months. Attrition rate was 14% and m
Like
Comment
Share
